Literature DB >> 9815935

Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer.

A Latil1, O Cussenot, G Fournier, J C Baron, R Lidereau.   

Abstract

It is widely accepted that an accumulation of genetic alterations plays an important role in the genesis of human cancers, but little is known about prostate cancer in this respect. Recent studies have identified regions on chromosome arms 8p, 10q, 16q, and 18q that are frequently deleted in human prostate cancer. We have previously described a loss of heterozygosity (LOH) at the Met locus on chromosome band 7q31 in a study of 20 localized prostate tumors. To determine whether a region on the 7q arm is important in the initiation and/or progression of prostate cancer, prostate tissue from 13 patients with confined prostate tumors, 17 with local extracapsular extension, and 13 with metastatic forms were analyzed for LOH, using a DNA probe for RFLP (pMetH) and 8 CA microsatellite repeats (7 on 7q21-q33 and 1 on 7p). Twenty (47%) of the 43 cases studied showed LOH at one or more 7q loci. The most frequently deleted region was chromosome 7q31.1-7q31.2, whereas the centromeric locus on 7q21 was generally conserved. The percentage of LOH was normally distributed around the D7S480 locus. Moreover, the rate of LOH in the 7q31 region was lower in metastatic tumors than in localized tumors. These results strongly suggest the presence of a tumor suppressor gene on the chromosome band 7q31 with an important role in the early stages of prostate cancer.

Entities:  

Mesh:

Year:  1995        PMID: 9815935

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  10 in total

1.  Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity.

Authors:  Marcel W Coolen; Clare Stirzaker; Jenny Z Song; Aaron L Statham; Zena Kassir; Carlos S Moreno; Andrew N Young; Vijay Varma; Terence P Speed; Mark Cowley; Paul Lacaze; Warren Kaplan; Mark D Robinson; Susan J Clark
Journal:  Nat Cell Biol       Date:  2010-02-21       Impact factor: 28.824

2.  Genomewide scan for prostate cancer-aggressiveness loci.

Authors:  J S Witte; K A Goddard; D V Conti; R C Elston; J Lin; B K Suarez; K W Broman; J K Burmester; J L Weber; W J Catalona
Journal:  Am J Hum Genet       Date:  2000-05-24       Impact factor: 11.025

3.  Identification of a new target region on the long arm of chromosome 7 in gastric carcinoma by loss of heterozygosity.

Authors:  De-Sheng Weng; Jin-Tian Li; Shi-Juan Mai; Zhi-Zhong Pan; Bing-Jian Feng; Qi-Sheng Feng; Li-Xi Huang; Qi-Jing Wang; Yong-Qiang Li; Xing-Juan Yu; Shi-Ping Chen; Jia He; Jian-Chuan Xia
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

4.  Fine-mapping of prostate cancer aggressiveness loci on chromosome 7q22-35.

Authors:  Xin Liu; Iona Cheng; Sarah J Plummer; Brian K Suarez; Graham Casey; William J Catalona; John S Witte
Journal:  Prostate       Date:  2010-10-13       Impact factor: 4.104

5.  Knockout mice reveal a tumor suppressor function for Testin.

Authors:  Alessandra Drusco; Nicola Zanesi; Claudia Roldo; Francesco Trapasso; John L Farber; Louise Y Fong; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-20       Impact factor: 11.205

Review 6.  Common fragile site tumor suppressor genes and corresponding mouse models of cancer.

Authors:  Alessandra Drusco; Yuri Pekarsky; Stefan Costinean; Anna Antenucci; Laura Conti; Stefano Volinia; Rami I Aqeilan; Kay Huebner; Nicola Zanesi
Journal:  J Biomed Biotechnol       Date:  2010-12-29

7.  Mutations in the ST7/RAY1/HELG locus rarely occur in primary colorectal, gastric, and hepatocellular carcinomas.

Authors:  S Yoshimura; T Yamada; S Ohwada; T Koyama; K Hamada; K Tago; I Sakamoto; I Takeyoshi; T Ikeya; F Makita; Y Iino; Y Morishita
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

8.  Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies.

Authors:  Phillippa J Neville; David V Conti; Pamela L Paris; Howard Levin; William J Catalona; Brian K Suarez; John S Witte; Graham Casey
Journal:  Neoplasia       Date:  2002 Sep-Oct       Impact factor: 5.715

9.  TES inhibits colorectal cancer progression through activation of p38.

Authors:  Huili Li; Kun Huang; Lu Gao; Lixia Wang; Yanfeng Niu; Hongli Liu; Zheng Wang; Lin Wang; Guobin Wang; Jiliang Wang
Journal:  Oncotarget       Date:  2016-07-19

10.  Mechanism of Histone H3K4me3 Recognition by the Plant Homeodomain of Inhibitor of Growth 3.

Authors:  Sophia Kim; Senthil Natesan; Gabriel Cornilescu; Samuel Carlson; Marco Tonelli; Urszula L McClurg; Olivier Binda; Craig N Robson; John L Markley; Stefan Balaz; Karen C Glass
Journal:  J Biol Chem       Date:  2016-06-08       Impact factor: 5.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.